1. The anterior gradient homologue 2 (AGR2) co-localises with the glucose-regulated protein 78 (GRP78) in cancer stem cells, and is critical for the survival and drug resistance of recurrent glioblastoma: in situ and in vitro analyses
   Deema Hussein et al, 2022, Cancer Cell International CrossRef
2. Immune evasion by cancer stem cells ensures tumor initiation and failure of immunotherapy
   Sourio Chakraborty et al, 2023, Exploration of Immunology CrossRef
3. Exploration of prognostic genes and risk signature in breast cancer patients based on RNA binding proteins associated with ferroptosis
   Xiang Chen et al, 2023, Frontiers in Genetics CrossRef
4. Radiation-Triggered Selenium-Engineered Mesoporous Silica Nanocapsules for RNAi Therapy in Radiotherapy-Resistant Glioblastoma
   Xianglong Tang et al, 2023, ACS Nano CrossRef
5. A Genomic Instability–Associated Prognostic Signature for Glioblastoma Patients
   Xiaodong Chen et al, 2022, World Neurosurgery CrossRef
6. Deciphering the role of CD47 in cancer immunotherapy
   Yu'e Liu et al, 2023, Journal of Advanced Research CrossRef
7. Immunoglobulin‐like transcript 2 blockade restores antitumor immune responses in glioblastoma
   Seila Lorenzo‐Herrero et al, 2023, Cancer Science CrossRef
8. Overexpression of GINS4 is associated with poor prognosis and survival in glioma patients
   Binfeng Liu et al, 2021, Molecular Medicine CrossRef